- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01125618
Millennium Villages Project in Sub-Saharan Africa (MVP)
A Pair-matched Community Intervention Trial to Assess the Impact of an Integrated Health and Development Intervention on Child Survival and the Millennium Development Goals in 10 Sub- Saharan African Countries
The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project works in partnership with governments in 10 African countries in areas where progress towards achieving the Millennium Development Goals has been insufficient.
The Project evaluation will test the following hypotheses:
- That after 5 years of operation, villages exposed to the MVP intervention will have a lower rate of under-5 mortality and parallel gains in MDG-related secondary outcomes when compared to similar villages not receiving the intervention.
- That the coordinated delivery a multi-sector package of health and development interventions implemented through a broad-based local partnership is feasible in a diversity of sub-Saharan African contexts, and;
- The intervention package can be delivered at a scalable cost of $40 per person per year in the health sector and $110 per person per year in total
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Design and population The design is a pair-matched community intervention trial. Village clusters with high levels of malnutrition were selected from rural areas in ten sub-Saharan African countries to reflect a diverse range of agro-ecological zones, farming systems, disease profiles, and infrastructure challenges. MVP sites represent 80 villages in 14 clusters across 10 countries, covering nearly 500,000 people. For each intervention cluster, a matched comparison cluster has been selected at random to participate in the evaluation.
Outcomes The primary outcome is the under-5 mortality rate. Secondary outcomes are levels of coverage with essential maternal-child health interventions and related MDG indicators for poverty, nutrition, education, and environmental health.
Sample size calculation The assessment follows 6000 households across intervention and matched comparison villages at baseline, and after 3 and 5 years of intervention exposure. With 10 paired clusters, the study is powered to detect a 40% difference in the U5MR between the two groups.
Analysis plan The analysis will use a two-staged pair-matched cluster level analysis, and will be complemented with multilevel modeling. Reporting will adhere to Transparent Reporting of Evaluations with Non-randomized Designs (TREND) guidelines.
Implementation science A portfolio of qualitative implementation science (process evaluation) will complement the quantitative assessment, and involves interviews with implementers, partners, and project beneficiaries. This analysis will address questions about: the feasibility of the interventions; the timing and sequence of their introduction; key contextual barriers and facilitators to implementation; and potential synergies achieved from the integrated multisector approach.
Economic costing study One project hypothesis is that an annual per capita investment of $110 is required to achieve the MDGs. The aim of the economic costing study is to document the absolute and relative contribution of project partners (MVP, government, donors, and the community) to all priced and non-priced cluster-level activities, as well as the sector-specific breakdown of these inputs.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Koraro, Ethiopie
- Koraro
-
-
-
-
-
Bonsasso, Ghana
- Bonsasso
-
-
-
-
-
Sauri, Kenya
- Sauri
-
-
-
-
-
Mwandama, Malawi
- Mwandama
-
-
-
-
-
Tiby, Mali
- Tiby
-
-
-
-
-
Ikaram, Nigeria
- Ikaram
-
Pampaida, Nigeria
- Pampaida
-
-
-
-
-
Ruhiira, Ouganda
- Ruhiira
-
-
-
-
-
Mayange, Rwanda
- Mayange
-
-
-
-
-
Potou, Sénégal
- Potou
-
-
-
-
-
Mbola, Tanzanie
- Mbola
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Resident in a Millennium Village and consenting to periodic assessments
Exclusion Criteria:
- Those not consenting to participate
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Non randomisé
- Modèle interventionnel: Affectation factorielle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: MVP village
Wealth stratified and randomly selected households residing in a village exposed to the Millennium Villages Project intervention (or health and development intervention package)
|
The timing and sequence of intervention vary by site, but include improved access to seed-fertilizer to increase agricultural production; improved market and capital access; proven maternal-newborn-child health interventions delivered free of cost at the point of service; improvements to school number and quality; and access to basic infrastructure including safe water, sanitation, electricity, transport and communication.
Autres noms:
|
Comparateur actif: Comparison village
Villages receiving routine services through established programs
|
Routine services and programs currently being administered using prevailing resources, at the current pace and with established partnerships.
There is no attempt to limit the introduction of new interventions or agencies into comparison sites.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Child Mortality Rate
Délai: 5 years
|
Under 5 Mortality Rate
|
5 years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Prevalence of Stunting
Délai: 5 years
|
Proportion of under 5s who are stunted; Stunted = low height for age Z-score
|
5 years
|
Prevalence of Diarrhea
Délai: 5 years
|
Proportion of under 5's with diarrhea in past 2 weeks
|
5 years
|
Prevalence of Malaria
Délai: 5 years
|
Prevalence of malaria among under 5s at the time of survey
|
5 years
|
Prevalence of antenatal care
Délai: 5 years
|
Proportion of women who receive at least 4 ANC visits
|
5 years
|
Survival rate to last grade of primary education (School Quality)
Délai: 5 years
|
5 years
|
|
Prevalence of improved sanitation utilization
Délai: 5 years
|
Proportion of the population using an improved sanitation source
|
5 years
|
Duration or breast feeding (Child feeding practices)
Délai: 5 years
|
5 years
|
|
Age of introduction of complementary feeding (Child feeding practices)
Délai: 5 years
|
5 years
|
|
Prevalence of bed net utilization
Délai: 5 years
|
Proportion of under 5s sleeping under Longlasting insecticide treated bednets in the night prior to the survey
|
5 years
|
Prevalence of malaria treatment
Délai: 5 years
|
Proportion of under 5s with a fever in the past 2 weeks who receive appropriate anti-malarial treatment
|
5 years
|
Prevalence of measles immunization
Délai: 5 years
|
Proportion under 1s immunized against measles
|
5 years
|
Prevalence of diarrhea management
Délai: 5 years
|
Proportion of under 5s with diarrhea in the past 2 weeks who received oral rehydration therapy
|
5 years
|
Prevalence of pneumonia management
Délai: 5 years
|
Proportion of under 5s treated for pneumonia in the past 2 weeks
|
5 years
|
Prevalence of newborn care
Délai: 5 years
|
Proportion of newborns receiving a post-natal check in the first week of life
|
5 years
|
Proportion of pregnant women who received and HIV test
Délai: 5 years
|
This measures the prevention of vertical transmission of HIV
|
5 years
|
Prevalence of food insecurity
Délai: 5 years
|
Proportion of households reporting not enough food for 1 of past 12 months
|
5 years
|
Institutional delivery rate
Délai: 5 years
|
Proportion of births attended by skilled health personnel
|
5 years
|
Prevalence of underweight
Délai: 5 years
|
Proportion of under 5s who are underweight; Underweight= weight for age Z score
|
5 years
|
Prevalence of wasting
Délai: 5 years
|
Proportion of under 5s who are wasted; Wasting = weight for height Z score
|
5 years
|
Prevalence of low mid-upper arm circumference
Délai: 5 years
|
Proportion of under 5s with a low mid-upper arm circumference
|
5 years
|
Household Asset Index (Household poverty)
Délai: 5 years
|
Survey of fixed and non-fixed assets, including recent purchases
|
5 years
|
Prevalence of improved water source utilization
Délai: 5 years
|
Proportion of the population using an improved drinking water source
|
5 years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Jeffrey Sachs, PhD, The Earth Institute, Columbia University
- Directeur d'études: Pedro Sanchez, PhD, The Earth Institute, Columbia University
- Chercheur principal: Cheryl Palm, PhD, The Earth Institute, Columbia University
- Chercheur principal: Sonia Sachs, MD, PhD, Director of Health, The Earth Institute, Columbia University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- AAAA8202
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Child Survival
-
RenJi HospitalComplétéRapport numération plaquettaire/diamètre de la rate | Classification de Child-PughChine
-
Stanford UniversityNational Cancer Institute (NCI)RésiliéCarcinome hépatocellulaire récurrent | Classe A de Child-Pugh | Classe B de Child-PughÉtats-Unis, Japon
-
Boehringer IngelheimPlus disponibleMaladies pulmonaires interstitielles (chez les populations pédiatriques) | Maladie pulmonaire interstitielle de l'enfant (CHILD)
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsComplétéClasse A de Child-Pugh | Carcinome hépatocellulaire de stade IIIA | Carcinome hépatocellulaire de stade IIIB | Carcinome hépatocellulaire de stade IIIC | Carcinome hépatocellulaire de stade IVA | Carcinome hépatocellulaire de stade IVB | Classe B de Child-PughÉtats-Unis
-
Centre Hospitalier Universitaire DijonComplétéCarcinome hépatocellulaire de Child-Pugh AFrance
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCActif, ne recrute pasCarcinome hépatocellulaire adulte avancé | Classe A de Child-Pugh | Carcinome hépatocellulaire de stade III | Carcinome hépatocellulaire de stade IIIA | Carcinome hépatocellulaire de stade IIIB | Carcinome hépatocellulaire de stade IIIC | Carcinome hépatocellulaire de stade IV | Carcinome hépatocellulaire... et d'autres conditionsÉtats-Unis
-
AstraZenecaRésiliéCancer de l'estomac | Malignités solides avancées | Tumeur solide | Carcinome hépatocellulaire avancé de Child-Pugh A à B7 | NSCLC EGFR et/ou mutant ROS | Carcinome des métastases pulmonairesCorée, République de
Essais cliniques sur Health and development intervention package
-
National University of SingaporeComplétéDéveloppement de l'enfantSingapour
-
Brigham and Women's HospitalNational Aeronautics and Space Administration (NASA)Complété
-
Attikon HospitalDepartment of Gastroenterology, Central Clinical School, Monash UniversityComplétéSyndrome du côlon irritable avec diarrhéeGrèce
-
Children's Hospital Medical Center, CincinnatiComplété
-
David Van SickleFoundation for a Healthy Kentucky; Norton Healthcare Foundation; Owsley Brown...ComplétéMaladies des voies respiratoires | Maladies du système immunitaire | Maladies pulmonaires | Hypersensibilité | Hypersensibilité immédiate | Maladies bronchiques | Maladies pulmonaires obstructives | Asthme | Hypersensibilité respiratoireÉtats-Unis
-
Nanyang Technological UniversitySheffield Hallam University; Université de Montréal; National Gallery Singapore...ComplétéQualité de vie | Fragilité | Art | Bien-être, PsychologiqueSingapour
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Recrutement
-
Children's Hospital Medical Center, CincinnatiComplété
-
Case Western Reserve UniversityNational Institute on Minority Health and Health Disparities (NIMHD)ComplétéComportement de santé | Don d'organeÉtats-Unis
-
University of Colorado, DenverNational Cancer Institute (NCI)RecrutementCancer pédiatrique | SurvieÉtats-Unis